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both the volume and centre of the GTV. The process of using 
co-registering MR-CT images increases the uncertainty and 
leads to larger volumes when compared to GTV delineation 
using MR only. Data from additional observers will help 
quantify the magnitude of GTV delineation uncertainties. The 
limitation of having outlines from a single non-expert 
observer will be addressed in the final publication. 
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Purpose or Objective: To evaluate long-term clinical results 
after intensity modulated radiotherapy technique (IMRT) on 
vaginal vault in post-operative low-risk endometrial cancer 
patients. 
 
Material and Methods: Patients enrolled in two sequential 
trials (June 2006-October 2014) were analysed. A radiopaque 
methacrylate vaginal applicator was placed in the vagina. 
Patients were planned in supine position and immobilized 
using a vacuum cushion. Each patient was instructed to 
follow a protocol of controlled bladder filling and rectal 
emptying. Three radiopaque markers (1 mm diameter) fixed 
on the applicator allowed to improve visualization on portals 
imaging. Radiotherapy was delivered on the upper two thirds 
of the residual vagina (CTV), daily identified by the 
radiopaque markers. A 5 mm isotropic margin was added to 
the CTV in order to define the planning target volume (PTV). 
A 7 beams step and shoot IMRT technique was used by means 
of Plato Sunrise and Ergo++ treatment planning systems. 
25Gy/5Gy per fraction in the first trial and 30Gy/6Gy in the 
second one were the doses delivered to PTV. Toxicity was 
scored by the CTC-AE v.3.0 scale. 
 
Results: 23 patients (median age 63 years, range 49-88; stage 
IA: 69.6%, IB: 21.7%, II: 8.7%; grading G1: 3; G2: 17; G3: 3) 
were included in this analysis. Seven patients received 
25Gy/5Gy and 16 received 30 Gy/6Gy per fraction. Proctitis 
and dysuria were the most common toxicities. Twelve 
patients (52.2%) developed late mild toxicity (G2: 1 rectal 
bleeding and 1 atrophic skin with plaque lesions). The most 
common late toxicity was G1 vulvar telangiectasia (26%), 
while 3 patients developed G1 vaginal stenosis (Table 1). 
 
 
With a median follow-up of 52 months (range 4-103) no 
vaginal recurrence was observed (5-year local control: 100%), 
while 4 patients developed pelvic or distance relapse (5-year 
disease-free survival: 86.4%). Five-year overall survival was 
100%. 
 
Conclusion: Endovaginal brachytherapy studies reported 0-
5.2% late severe toxicity. Most toxicities were vaginal and 
urethral stenosis or rectal vaginal fistula, not observed in our 
study. In conclusion postoperative IMRT on vaginal vault 
showed promising clinical long-term results. 
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Purpose or Objective: The current study aims to evaluate 
the outcomes in patients treated with radical radiotherapy 
for cervical cancer who received external beam radiotherapy 
(EBRT) boost in place of intracavitary brachytherapy (ICBT).  
 
Material and Methods: We performed a multicenter 
retrospective study on the patients with cervical cancer 
treated with external beam boost as a substitution of ICBT 
during the period of January 2005 through October 2012 in 11 
participating radiation oncology centers in Korea. Treatment 
outcome, prognostic factor, and toxicity were evaluated.  
 
Results: Seventy-five patients were identified. The median 
age of the patients was 58 years (range, 33-92 years). The 
clinical stages were I in 6, II in 34, III in 18, and IVA in 17 
patients. Concurrent chemotherapy was performed to 64 
patients (85.3%). Radiation doses were median 46 Gy (range, 
40-54 Gy) for whole pelvis and 24 Gy (range, 9-35 Gy) for 
tumor boost. Three-dimensional radiotherapy (in 24 patients) 
or intensity-modulated radiotherapy (in 51 patients) was used 
for tumor boost. On images taken 3-6 months after 
radiotherapy, 46 patients showed complete response (CR), 24 
had partial response, and 2 were found to have progressive 
disease. The median follow-up time was 33 months. Disease 
progression was found in 30 patients (40.0%). Among these 
patients, 21 (28.0%) showed local progression with a median 
time to progression of 29 months (range, 3-101 months). The 
5-year local progression-free survival (LPFS) rate was 70.0%. 
On uni- and multivariate analyses, treatment response at 3-6 
